Anavex Life Sciences
AVXL
#7563
Rank
โ‚ฌ0.33 B
Marketcap
3,78ย โ‚ฌ
Share price
-1.12%
Change (1 day)
-50.95%
Change (1 year)

Anavex Life Sciences (AVXL) - Cash on Hand

Cash on Hand as of June 2025 : โ‚ฌ86.88 Million

According to Anavex Life Sciences 's latest financial reports the company has โ‚ฌ86.88 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Anavex Life Sciences - Cash on Hand chart (from 2005 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-09-30โ‚ฌ0.11 B-16.8%
2023-09-30โ‚ฌ0.14 B-6.42%
2022-09-30โ‚ฌ0.15 B16%
2021-09-30โ‚ฌ0.13 B426.86%
2020-09-30โ‚ฌ24.94 M22.55%
2019-09-30โ‚ฌ20.35 M3.02%
2018-09-30โ‚ฌ19.75 M-15.45%
2017-09-30โ‚ฌ23.37 M185.13%
2016-09-30โ‚ฌ8.19 M-40.11%
2015-09-30โ‚ฌ13.68 M138%
2014-09-30โ‚ฌ5.75 M2153.98%
2013-09-30โ‚ฌ0.25 M2776.27%
2012-09-30โ‚ฌ0 M-91.06%
2011-09-30โ‚ฌ0.09 M-48.92%
2010-09-30โ‚ฌ0.19 M-19.65%
2009-09-30โ‚ฌ0.24 M5231.31%
2008-09-30โ‚ฌ0 M25726.92%
2007-09-30โ‚ฌ0 M-99.82%
2006-09-30โ‚ฌ0 M1092.59%
2005-09-30โ‚ฌ0 M-96.41%
2004-09-30โ‚ฌ0.02 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚ฌ0.58 B 569.15%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚ฌ0.18 B 110.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
โ‚ฌ0.36 B 316.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
โ‚ฌ2.16 M-97.51%๐Ÿ‡บ๐Ÿ‡ธ USA